PURPOSE: This qualitative study explored women's experiences with counseling about medication-induced birth defects, as well as how and when they would like to receive information on medication-induced birth defects from their health care providers (HCPs). METHODS: We conducted four focus groups with 36 women of reproductive age (18-45 years old) in Pittsburgh, Pennsylvania. Twenty-one women were using medications to treat a chronic health condition, and two were pregnant. Content analysis was performed by three independent coders using a grounded theory approach. Discrepancies were resolved by consensus. RESULTS: Women reported depending on their HCPs for information about the risks of teratogenic effects of medications on a pregnancy, but felt the information they had been provided was not always comprehensive. Women want HCPs to initiate discussions about potentially teratogenic medications at the time the medications are prescribed, regardless of whether the woman is sexually active or planning a pregnancy. Women want clear information about all potential outcomes for a fetus. Factors women reported as being critical to effective teratogenic risk counseling included privacy, sufficient time to discuss the topic, and a trusting relationship with their HCP. CONCLUSIONS: Women of reproductive age think that providing information about the possible teratogenic effects of medications could be improved by routine discussions of teratogenic risks at the time medications are prescribed. Copyright 2009 Wiley-Liss, Inc.
PURPOSE: This qualitative study explored women's experiences with counseling about medication-induced birth defects, as well as how and when they would like to receive information on medication-induced birth defects from their health care providers (HCPs). METHODS: We conducted four focus groups with 36 women of reproductive age (18-45 years old) in Pittsburgh, Pennsylvania. Twenty-one women were using medications to treat a chronic health condition, and two were pregnant. Content analysis was performed by three independent coders using a grounded theory approach. Discrepancies were resolved by consensus. RESULTS:Women reported depending on their HCPs for information about the risks of teratogenic effects of medications on a pregnancy, but felt the information they had been provided was not always comprehensive. Women want HCPs to initiate discussions about potentially teratogenic medications at the time the medications are prescribed, regardless of whether the woman is sexually active or planning a pregnancy. Women want clear information about all potential outcomes for a fetus. Factors women reported as being critical to effective teratogenic risk counseling included privacy, sufficient time to discuss the topic, and a trusting relationship with their HCP. CONCLUSIONS:Women of reproductive age think that providing information about the possible teratogenic effects of medications could be improved by routine discussions of teratogenic risks at the time medications are prescribed. Copyright 2009 Wiley-Liss, Inc.
Authors: Kay Johnson; Samuel F Posner; Janis Biermann; José F Cordero; Hani K Atrash; Christopher S Parker; Sheree Boulet; Michele G Curtis Journal: MMWR Recomm Rep Date: 2006-04-21
Authors: Eleanor Bimla Schwarz; Debbie A Postlethwaite; Yun-Yi Hung; Mary Anne Armstrong Journal: Ann Intern Med Date: 2007-09-18 Impact factor: 25.391
Authors: Joyce Elsinga; Lieke C de Jong-Potjer; Karin M van der Pal-de Bruin; Saskia le Cessie; Willem J J Assendelft; Simone E Buitendijk Journal: Womens Health Issues Date: 2008 Nov-Dec
Authors: Susan E Andrade; Jerry H Gurwitz; Robert L Davis; K Arnold Chan; Jonathan A Finkelstein; Kris Fortman; Heather McPhillips; Marsha A Raebel; Douglas Roblin; David H Smith; Marianne Ulcickas Yood; Abraham N Morse; Richard Platt Journal: Am J Obstet Gynecol Date: 2004-08 Impact factor: 8.661
Authors: Karin M van der Pal-de Bruin; Saskia le Cessie; Joyce Elsinga; Lieke C de Jong-Potjer; Arie van Haeringen; Arie Knuistingh Neven; S Pauline Verloove-Vanhorick; Pim Assendelft Journal: Paediatr Perinat Epidemiol Date: 2008-05 Impact factor: 3.980
Authors: Sheila K Mody; Jennifer Wu; Marla Ornelas; Colleen Kernahan; Elizabeth Salas; Kelly Kao; Robert Felix; Christina Chambers Journal: Birth Defects Res A Clin Mol Teratol Date: 2015-06-23
Authors: Eleanor Bimla Schwarz; Sara M Parisi; Sanithia L Williams; Grant J Shevchik; Rachel Hess Journal: Ann Fam Med Date: 2012 Nov-Dec Impact factor: 5.166
Authors: Eleanor Bimla Schwarz; Sara M Parisi; Steven M Handler; Gideon Koren; Elan D Cohen; Grant J Shevchik; Gary S Fischer Journal: J Gen Intern Med Date: 2012-07 Impact factor: 5.128
Authors: Tiffany Behringer; Bruce L Rollman; Bea Herbeck-Belnap; Patricia R Houck; Sati Mazumdar; Eleanor Bimla Schwarz Journal: Prim Care Companion CNS Disord Date: 2011
Authors: Molly M Lynch; Linda B Squiers; Katherine M Kosa; Suzanne Dolina; Jennifer Gard Read; Cheryl S Broussard; Meghan T Frey; Kara N Polen; Jennifer N Lind; Suzanne M Gilboa; Janis Biermann Journal: Matern Child Health J Date: 2018-01
Authors: Eleanor Bimla Schwarz; Sara M Parisi; Steven M Handler; Gideon Koren; Grant Shevchik; Gary S Fischer Journal: J Womens Health (Larchmt) Date: 2013-08-09 Impact factor: 2.681
Authors: Molly M Lynch; Jacqueline B Amoozegar; Emily M McClure; Linda B Squiers; Cheryl S Broussard; Jennifer N Lind; Kara N Polen; Meghan T Frey; Suzanne M Gilboa; Janis Biermann Journal: Qual Health Res Date: 2017-10-03